A case filed in Delaware Superior Court is the first anywhere to claim Aziyo Inc. was negligent in sending out a bone marrow product thought to be contaminated with tuberculosis, but attorneys for the Delaware plaintiff say similar cases are expected to be filed soon.
June 17, 2021 at 05:04 PM
3 minute read
The original version of this story was published on Delaware Law Weekly
A Philadelphia firm is the first to take legal action against the manufacturer of a batch of a bone graft product that’s reported to have caused patients to contract tuberculosis post-surgery.
The lot of FiberCel, the product made by Delaware-based biotechnology company Aziyo Inc., included 154 units distributed across 20 states, and the company has recognized at least four patients who received FiberCel from that lot have developed tuberculosis.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
